|
|
Office Locations:
|
1105 Castle Court
Austin, TX 78703
| |
|
|
|
|
|
|
Consumer Products & Services
Life Sciences & Healthcare
|
|
|
|
ETI is a venture capital firm that specializes in forming, funding, commercializing, and managing companies for the purpose of converting institutional and university-based technology into high return ventures. Emergent becomes a full time business partner and acts as an active management team with a portfolio company. Once the technology is proven and markets are demonstrated, ultimate value may be achieved through a sublicense, IPO or sale of the technology. As of 2018, Emergent and its industry partners have invested in excess of $500 million in technologies within its 19 portfolio companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
